Variant report
Variant | rs7589484 |
---|---|
Chromosome Location | chr2:20565123-20565124 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:20551600-20568800 | Weak transcription | Psoas Muscle | Psoas |
2 | chr2:20556800-20569200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr2:20564200-20566000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
4 | chr2:20564400-20566000 | Flanking Active TSS | GM12878-XiMat | blood |
5 | chr2:20564400-20567200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr2:20564400-20567200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr2:20564400-20567200 | Enhancers | HMEC | breast |
8 | chr2:20564800-20565400 | Enhancers | Osteobl | bone |
9 | chr2:20564800-20565600 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
10 | chr2:20564800-20565800 | Enhancers | NH-A | brain |
11 | chr2:20564800-20566400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr2:20564800-20566600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr2:20564800-20566600 | Enhancers | NHDF-Ad | bronchial |
14 | chr2:20564800-20567200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr2:20564800-20567200 | Enhancers | NHEK | skin |
16 | chr2:20565000-20565200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr2:20565000-20565200 | Bivalent Enhancer | HepG2 | liver |
18 | chr2:20565000-20565400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
19 | chr2:20565000-20565600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr2:20565000-20565600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
21 | chr2:20565000-20565600 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
22 | chr2:20565000-20565600 | Enhancers | Esophagus | oesophagus |
23 | chr2:20565000-20565600 | Flanking Active TSS | A549 | lung |
24 | chr2:20565000-20565600 | Enhancers | HSMMtube | muscle |
25 | chr2:20565000-20565800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
26 | chr2:20565000-20565800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
27 | chr2:20565000-20565800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
28 | chr2:20565000-20565800 | Enhancers | Primary monocytes fromperipheralblood | blood |
29 | chr2:20565000-20565800 | Enhancers | Placenta Amnion | Placenta Amnion |
30 | chr2:20565000-20565800 | Enhancers | HSMM | muscle |
31 | chr2:20565000-20565800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
32 | chr2:20565000-20565800 | Enhancers | NHLF | lung |
33 | chr2:20565000-20566000 | Enhancers | Muscle Satellite Cultured Cells | -- |
34 | chr2:20565000-20567200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
35 | chr2:20565000-20570200 | Enhancers | Placenta | Placenta |